Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
The editor has retracted this article [1] because Figures 2 and 4 contain duplicated and modified figures from [2–4]. The data reported in this article are therefore unreliable.
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Cancer Cell International |
Online Access: | https://doi.org/10.1186/s12935-019-1083-8 |
_version_ | 1818364012415418368 |
---|---|
author | Xiaoyan Ding Wei Sun Jinglong Chen |
author_facet | Xiaoyan Ding Wei Sun Jinglong Chen |
author_sort | Xiaoyan Ding |
collection | DOAJ |
description | The editor has retracted this article [1] because Figures 2 and 4 contain duplicated and modified figures from [2–4]. The data reported in this article are therefore unreliable. |
first_indexed | 2024-12-13T21:57:36Z |
format | Article |
id | doaj.art-996f4ff7dc084c8f859daf03841458f1 |
institution | Directory Open Access Journal |
issn | 1475-2867 |
language | English |
last_indexed | 2024-12-13T21:57:36Z |
publishDate | 2019-12-01 |
publisher | BMC |
record_format | Article |
series | Cancer Cell International |
spelling | doaj.art-996f4ff7dc084c8f859daf03841458f12022-12-21T23:30:05ZengBMCCancer Cell International1475-28672019-12-011911110.1186/s12935-019-1083-8Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathwayXiaoyan Ding0Wei Sun1Jinglong Chen2Cancer Center, Beijing Ditan Hospital, Capital Medical UniversityCancer Center, Beijing Ditan Hospital, Capital Medical UniversityCancer Center, Beijing Ditan Hospital, Capital Medical UniversityThe editor has retracted this article [1] because Figures 2 and 4 contain duplicated and modified figures from [2–4]. The data reported in this article are therefore unreliable.https://doi.org/10.1186/s12935-019-1083-8 |
spellingShingle | Xiaoyan Ding Wei Sun Jinglong Chen Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway Cancer Cell International |
title | Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway |
title_full | Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway |
title_fullStr | Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway |
title_full_unstemmed | Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway |
title_short | Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway |
title_sort | retraction note to il 2 augments the sorafenib induced apoptosis in liver cancer by promoting mitochondrial fission and activating the jnk taz pathway |
url | https://doi.org/10.1186/s12935-019-1083-8 |
work_keys_str_mv | AT xiaoyanding retractionnotetoil2augmentsthesorafenibinducedapoptosisinlivercancerbypromotingmitochondrialfissionandactivatingthejnktazpathway AT weisun retractionnotetoil2augmentsthesorafenibinducedapoptosisinlivercancerbypromotingmitochondrialfissionandactivatingthejnktazpathway AT jinglongchen retractionnotetoil2augmentsthesorafenibinducedapoptosisinlivercancerbypromotingmitochondrialfissionandactivatingthejnktazpathway |